{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:41:52Z","timestamp":1781901712232,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"German Center for Infection Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German National Department for Education and Research"},{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.vaccine.2018.09.016","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T09:45:28Z","timestamp":1537523128000},"page":"7083-7094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Dynamic changes of circulating miRNAs induced by the Ebola virus vaccine VSV-EBOV"],"prefix":"10.1016","volume":"36","author":[{"given":"T.","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Spohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Olearo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Zinser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahel","family":"Kasonta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.C.","family":"Stubbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rechtien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schmiedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.W.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Grundhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Addo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dahlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.vaccine.2018.09.016_b0005","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","article-title":"Phase 1 trials of rVSV Ebola vaccine in Africa and Europe","volume":"374","author":"Agnandji","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.016_b0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1414216","article-title":"A recombinant vesicular stomatitis virus Ebola vaccine","volume":"376","author":"Regules","year":"2017","journal-title":"N Engl J Med"},{"issue":"10068","key":"10.1016\/j.vaccine.2018.09.016_b0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.09.016_b0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ebiom.2017.03.045","article-title":"Dose-dependent T-cell dynamics and cytokine cascade following rVSV-ZEBOV immunization","volume":"19","author":"Dahlke","year":"2017","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.vaccine.2018.09.016_b0025","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","article-title":"The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1\/2 trial","volume":"15","author":"Huttner","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2018.09.016_b0030","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.celrep.2017.08.023","article-title":"Systems vaccinology identifies an early innate immune signature as a correlate of antibody responses to the Ebola vaccine rVSV-ZEBOV","volume":"20","author":"Rechtien","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2018.09.016_b0035","first-page":"9(385)","article-title":"A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa","author":"Huttner","year":"2017","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.vaccine.2018.09.016_b0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"issue":"3","key":"10.1016\/j.vaccine.2018.09.016_b0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.coi.2008.05.005","article-title":"MicroRNAs grow up in the immune system","volume":"20","author":"Hoefig","year":"2008","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.016_b0050","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.coph.2009.05.003","article-title":"microRNAs and the immune response","volume":"9","author":"Tsitsiou","year":"2009","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.09.016_b0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nri2252","article-title":"Micromanagement of the immune system by microRNAs","volume":"8","author":"Lodish","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2018.09.016_b0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri.2016.40","article-title":"MicroRNAs as regulatory elements in immune system logic","volume":"16","author":"Mehta","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"19","key":"10.1016\/j.vaccine.2018.09.016_b0065","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1182\/blood-2008-09-178186","article-title":"Patterns of microRNA expression characterize stages of human B-cell differentiation","volume":"113","author":"Zhang","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.vaccine.2018.09.016_b0070","first-page":"131","article-title":"Mechanism of T cell regulation by microRNAs","volume":"10","author":"Liu","year":"2013","journal-title":"Cancer Biol Med"},{"issue":"5824","key":"10.1016\/j.vaccine.2018.09.016_b0075","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1139253","article-title":"Requirement of bic\/microRNA-155 for normal immune function","volume":"316","author":"Rodriguez","year":"2007","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2018.09.016_b0080","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2007.10.009","article-title":"microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells","volume":"27","author":"Vigorito","year":"2007","journal-title":"Immunity"},{"issue":"5824","key":"10.1016\/j.vaccine.2018.09.016_b0085","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1126\/science.1141229","article-title":"Regulation of the germinal center response by microRNA-155","volume":"316","author":"Thai","year":"2007","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.vaccine.2018.09.016_b0090","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.celrep.2017.08.060","article-title":"miR-150 regulates memory CD8 T cell differentiation via c-Myb","volume":"20","author":"Chen","year":"2017","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2018.09.016_b0095","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1038\/s41598-017-02697-x","article-title":"MicroRNA-150 modulates intracellular Ca (2+) levels in naive CD8(+) T cells by targeting TMEM20","volume":"7","author":"Kim","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2018.09.016_b0100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.it.2008.04.004","article-title":"microRNAs and the immune response","volume":"29","author":"Lindsay","year":"2008","journal-title":"Trends Immunol"},{"issue":"33","key":"10.1016\/j.vaccine.2018.09.016_b0105","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2018.09.016_b0110","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1042\/BST0361211","article-title":"Role of miRNA-146a in the regulation of the innate immune response and cancer","volume":"36","author":"Williams","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.vaccine.2018.09.016_b0115","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3389\/fmicb.2016.01274","article-title":"Circulating MicroRNAs: potential and emerging biomarkers for diagnosis of human infectious diseases","volume":"7","author":"Verma","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2018.09.016_b0120","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3389\/fimmu.2017.01182","article-title":"The clinical application of microRNAs in infectious disease","volume":"8","author":"Drury","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.09.016_b0125","article-title":"Emerging role of circulating microRNA in the diagnosis of human infectious diseases","author":"Ojha","year":"2018","journal-title":"J Cell Physiol"},{"issue":"8","key":"10.1016\/j.vaccine.2018.09.016_b0130","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","article-title":"MicroRNAs in cancer: biomarkers, functions and therapy","volume":"20","author":"Hayes","year":"2014","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.vaccine.2018.09.016_b0135","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.micpath.2017.10.003","article-title":"Circulating microRNAs as a biomarker to predict therapy efficacy in hepatitis C patients with different genotypes","volume":"112","author":"Fan","year":"2017","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2018.09.016_b0140","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fcell.2017.00086","article-title":"microRNAs make the call in cancer personalized medicine","volume":"5","author":"Detassis","year":"2017","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"10.1016\/j.vaccine.2018.09.016_b0145","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.09.016_b0150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00430-015-0438-6","article-title":"Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus","volume":"205","author":"Krahling","year":"2016","journal-title":"Med Microbiol Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2018.09.016_b0155","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1101\/gr.092759.109","article-title":"Circos: an information aesthetic for comparative genomics","volume":"19","author":"Krzywinski","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.vaccine.2018.09.016_b0160","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fimmu.2017.00118","article-title":"Circulating microRNAs as potential biomarkers of infectious disease","volume":"8","author":"Correia","year":"2017","journal-title":"Front Immunol"},{"issue":"20","key":"10.1016\/j.vaccine.2018.09.016_b0165","doi-asserted-by":"crossref","first-page":"11244","DOI":"10.1128\/JVI.01248-13","article-title":"Soluble interleukin-6 receptor-mediated innate immune response to DNA and RNA viruses","volume":"87","author":"Wang","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.09.016_b0170","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3389\/fmicb.2017.00824","article-title":"Viruses and miRNAs: more friends than foes","volume":"8","author":"Bruscella","year":"2017","journal-title":"Front Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2018.09.016_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075348","article-title":"Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation","volume":"8","author":"de Candia","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2018.09.016_b0180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12985-018-0963-1","article-title":"The expression profile of human peripheral blood mononuclear cell miRNA is altered by antibody-dependent enhancement of infection with dengue virus serotype 3","volume":"15","author":"Jiang","year":"2018","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2018.09.016_b0185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fgene.2013.00119","article-title":"Circulating miRNAs: cell-cell communication function?","volume":"4","author":"Turchinovich","year":"2013","journal-title":"Front Genet"},{"key":"10.1016\/j.vaccine.2018.09.016_b0190","first-page":"1","article-title":"The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials","author":"Suder","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.vaccine.2018.09.016_b0195","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1016\/j.celrep.2017.08.065","article-title":"miR-150-mediated foxo1 regulation programs CD8(+) T cell differentiation","volume":"20","author":"Ban","year":"2017","journal-title":"Cell Rep"},{"issue":"6249","key":"10.1016\/j.vaccine.2018.09.016_b0200","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aab3920","article-title":"Ebola vaccine. VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain","volume":"349","author":"Marzi","year":"2015","journal-title":"Science"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2018.09.016_b0205","doi-asserted-by":"crossref","first-page":"S1066","DOI":"10.1093\/infdis\/jir348","article-title":"Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy","volume":"204","author":"Marzi","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.016_b0210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1590\/0074-02760160404","article-title":"Overexpression of miR-484 and miR-744 in Vero cells alters Dengue virus replication","volume":"112","author":"Castrillon-Betancur","year":"2017","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"3","key":"10.1016\/j.vaccine.2018.09.016_b0215","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7150\/jca.6799","article-title":"Potential urinary miRNA biomarker candidates for the accurate detection of prostate cancer among benign prostatic hyperplasia patients","volume":"5","author":"Haj-Ahmad","year":"2014","journal-title":"J Cancer"},{"key":"10.1016\/j.vaccine.2018.09.016_b0220","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fimmu.2018.00661","article-title":"A serum circulating miRNA signature for short-term risk of progression to active tuberculosis among household contacts","volume":"9","author":"Duffy","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.09.016_b0225","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.virol.2014.01.004","article-title":"Integrated analysis of microRNAs and their disease related targets in the brain of mice infected with West Nile virus","volume":"452\u2013453","author":"Kumar","year":"2014","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2018.09.016_b0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbrc.2010.03.091","article-title":"Analysis of microRNAs induced by Venezuelan equine encephalitis virus infection in mouse brain","volume":"395","author":"Bhomia","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2018.09.016_b0235","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ni.2767","article-title":"The miR-126-VEGFR2 axis controls the innate response to pathogen-associated nucleic acids","volume":"15","author":"Agudo","year":"2014","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.09.016_b0240","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","article-title":"Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6","volume":"19","author":"Jego","year":"2003","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.vaccine.2018.09.016_b0245","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02048-16","article-title":"MicroRNA miR-126-5p enhances the inflammatory responses of monocytes to lipopolysaccharide stimulation by suppressing cylindromatosis in chronic HIV-1 infection","volume":"91","author":"Huang","year":"2017","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2018.09.016_b0250","article-title":"miR-146 and miR-155: two key modulators of immune response and tumor development","volume":"3","author":"Testa","year":"2017","journal-title":"Noncoding RNA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T14:40:38Z","timestamp":1565275238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18312659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":50,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0264410X18312659"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic changes of circulating miRNAs induced by the Ebola virus vaccine VSV-EBOV","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}